Management of Refractory Central Vein Stenosis in Hemodialysis Patient

Main Article Content

Pradhika Perdana Sakti
Novi Kurnianingsih


BACKGROUND: Patient with hemodialysis (HD) is prone to central venous stenosis (CVS). The presence of CVS contributed to poor dialysis adequacy. Symptomatic CVS is treated with percutaneous transluminal angioplasty (PTA) with or without a stent. This report aimed to understand the characteristics of PTA with or without a stent.

CASE PRESENTATION: A 43-year-old woman was admitted to the hospital with a chief complaint of a deteriorating swollen right arm with pain 1 week prior. Patient had been on HD since 2019, had AV shunt access, continuous ambulatory peritoneal dialysis (CAPD), and 4 times balloon angioplasty due to similar complaints. Diagnoses of the patient were AV shunt stenosis, chronic kidney disease Stage 5 on CAPD, heart failure Stage C FC II, hypertension on treatment, anemia related to renal disease, and severe hypoalbuminemia based on anamnesis and extensive examination. PTA with stent was conducted in this patient and showed TIMI Flow III.

CONCLUSION: PTA is the primary treatment for symptomatic CVS. A stent implantation is used in cases that failed PTA treatment. PTA with a stent provides immediate symptom alleviation and benefits an angioplasty-resistant lesion by secondary patency.


Download data is not yet available.

Article Details

How to Cite
Sakti PP, Kurnianingsih N. Management of Refractory Central Vein Stenosis in Hemodialysis Patient. SEE J Cardiol [Internet]. 2023 Aug. 30 [cited 2023 Dec. 2];4(1):60-2. Available from:
Interventional Cardiology


Cantador AA, Pinheiro LL, Guillaumon AT. Endovascular treatment of central vein occlusion in patients with functioning arteriovenous fistulas. J Vasc Bras. 2022;21:e20210130. PMid:35399342 DOI:

Agarwal AK. Central vein stenosis. Am J Kidney Dis. 2013;61(6):1001-15. PMid:23291234 DOI:

Dhamija R, Asif A. Central venous stenosis. In: Yevzlin AS, Salman L, Ramani K, Qaqish SS, Vachharajani TJ, editors. Interventional Nephrology: Principles and Practice. Cham: Springer International Publishing; 2022. p. 141-2. DOI:

Horikawa M, Quencer KB. Central venous interventions. Tech Vasc Interv Radiol. 2017;20(1):48-57. PMid:28279409 DOI:

Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1-164. PMid:32778223 DOI:

Horita Y. Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients. J Vasc Access. 2019;20(1 suppl):87-92. PMid:29529914 DOI:

Kaw LL Jr., Manapat AE, Maglaya PL. Treatment options for hemodialysis-related central vein occlusive disease: Case series and review of literature. Acta Med Philipp. 2023;1-6. DOI:

Ashwal AJ, Razak UK, Padmakumar R, Pai U, Sudhakar M. Percutaneous intervention for symptomatic central vein stenosis in patients with upper limb arteriovenous dialysis access. Indian Heart J. 2018;70(5):690-8. PMid:30392508 DOI:

Ozyer U, Harman A, Yildirim E, Aytekin C, Karakayali F, Boyvat F. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: A 10-year single-center experience. AJR Am J Roentgenol. 2009;193(6):1672-9. PMid:19933663 DOI: